Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$411M |
| 2 |
Microsoft
MSFT
|
+$309M |
| 3 |
ExxonMobil
XOM
|
+$258M |
| 4 |
Johnson & Johnson
JNJ
|
+$221M |
| 5 |
GE Aerospace
GE
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$58.7M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$57.9M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$54.7M |
| 4 |
Stellantis
STLA
|
+$25.2M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.83% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Consumer Staples | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KEYW
2426
DELISTED
The KEYW Holding Corporation
KEYW
| $368K | ﹤0.01% |
57,300
+10,600
| +23% | +$58.7K |
|
2427
Iovance Biotherapeutics
IOVA
$2.94B
| $367K | ﹤0.01% |
74,600
+13,000
| +21% | +$71.1K |
|
2428
Titan Machinery
TITN
$438M
| $367K | ﹤0.01% |
32,800
+5,500
| +20% | +$54.1K |
|
|
TSC
2429
DELISTED
TriState Capital Holdings, Inc.
TSC
| $366K | ﹤0.01% |
30,338
+6,800
| +29% | +$83.3K |
|
|
BBBY
2430
Bed Bath & Beyond
BBBY
$407M
| $365K | ﹤0.01% |
35,005
+6,522
| +23% | +$63.7K |
|
|
EXAC
2431
DELISTED
Exactech Inc
EXAC
| $365K | ﹤0.01% |
18,591
+7,542
| +68% | +$142K |
|
2432
Kratos Defense & Security Solutions
KTOS
$12B
| $363K | ﹤0.01% |
76,100
+15,400
| +25% | +$55.6K |
|
|
SPNS
2433
DELISTED
Sapiens International
SPNS
| $362K | ﹤0.01% |
31,760
+22,990
| +262% | +$246K |
|
|
ACAT
2434
DELISTED
Arctic Cat Inc
ACAT
| $361K | ﹤0.01% |
22,200
+4,200
| +23% | +$63.4K |
|
|
PHIIK
2435
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $361K | ﹤0.01% |
19,800
+3,600
| +22% | +$63.4K |
|
2436
Lifecore Biomedical
LFCR
$183M
| $360K | ﹤0.01% |
35,700
+7,400
| +26% | +$81.3K |
|
2437
Vicor
VICR
$9.72B
| $359K | ﹤0.01% |
35,232
+5,300
| +18% | +$45.6K |
|
2438
Global Indemnity Group
GBLI
$407M
| $358K | ﹤0.01% |
12,000
+2,700
| +29% | +$79K |
|
|
RGLS
2439
DELISTED
Regulus Therapeutics
RGLS
| $358K | ﹤0.01% |
444
+77
| +21% | +$61.3K |
|
2440
A10 Networks
ATEN
$1.97B
| $355K | ﹤0.01% |
61,700
+9,500
| +18% | +$56.6K |
|
2441
PC Connection
CNXN
$2.04B
| $354K | ﹤0.01% |
14,300
+3,200
| +29% | +$73.1K |
|
2442
Standard BioTools
LAB
$309M
| $354K | ﹤0.01% |
45,500
+9,300
| +26% | +$67.1K |
|
2443
Workiva
WK
$3.76B
| $354K | ﹤0.01% |
31,521
+6,100
| +24% | +$80.4K |
|
2444
The Bancorp
TBBK
$2.83B
| $352K | ﹤0.01% |
63,500
+10,800
| +20% | +$53.9K |
|
|
AAC
2445
DELISTED
AAC Holdings
AAC
| $352K | ﹤0.01% |
18,300
+9,100
| +99% | +$172K |
|
2446
Northern Oil and Gas
NOG
$2.58B
| $351K | ﹤0.01% |
9,085
+1,705
| +23% | +$58K |
|
|
SALE
2447
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $351K | ﹤0.01% |
45,500
+8,800
| +24% | +$71.7K |
|
2448
Clear Channel Outdoor Holdings
CCO
$1.23B
| $350K | ﹤0.01% |
76,800
+12,700
| +20% | +$56.2K |
|
|
TA
2449
DELISTED
TravelCenters of America LLC
TA
| $348K | ﹤0.01% |
10,640
+1,960
| +23% | +$75.8K |
|
|
CNCE
2450
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $348K | ﹤0.01% |
26,292
+11,292
| +75% | +$163K |
|
Similar funds
Swiss National Bank's Q1 2016 Portfolio in Review
As of Q1 2016, Swiss National Bank held 2,649 positions worth $54.5B, up 32% from $41.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Swiss National Bank deployed $13.6B of net new capital in Q1 2016, opening 6 new positions and adding to 2,585 existing holdings. Its largest new stake was Ferrari: 823,472 shares worth $32.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Stellantis, an estimated $25.2M trimmed.
- Swiss National Bank's largest Q1 2016 buy was Ferrari: 823,472 shares worth $32.9M.
- Swiss National Bank added most to Apple in Q1 2016, an estimated $411M increase.
- Swiss National Bank's biggest Q1 2016 reduction was Stellantis, cutting an estimated $25.2M.
- Swiss National Bank fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $58.7M.
- Swiss National Bank's ten largest holdings make up 15% of its $54.5B portfolio in Q1 2016.
- Swiss National Bank opened 6 new positions and closed 38 in Q1 2016.
- Swiss National Bank's portfolio value rose 32% quarter-over-quarter to $54.5B.
Based on Swiss National Bank's 13F filing for Q1 2016, filed 4 May 2016.